Labcorp Holdings Inc. financial data

Symbol
LH on NYSE
Industry
Services-Medical Laboratories
Location
358 S Main St, Burlington, North Carolina
Fiscal year end
December 31
Former names
LABORATORY CORP OF AMERICA HOLDINGS (to 5/16/2024), NATIONAL HEALTH LABORATORIES HOLDINGS INC (to 2/13/1995)
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -40.8%
Quick Ratio 13.1 % -26.7%
Debt-to-equity 111 % +12.9%
Return On Equity 5.67 % -32.9%
Return On Assets 2.69 % -37%
Operating Margin 5.97 % -27.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84M shares -5.23%
Common Stock, Shares, Outstanding 83.8M shares -5.52%
Entity Public Float 17.3B USD -14.4%
Common Stock, Value, Issued 7.7M USD -4.94%
Weighted Average Number of Shares Outstanding, Basic 84.1M shares -5.19%
Weighted Average Number of Shares Outstanding, Diluted 84.3M shares -5.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.5B USD +12.4%
Cost of Revenue 8.99B USD +14%
Operating Income (Loss) 746M USD -18.6%
Income Tax Expense (Benefit) 206M USD +91.6%
Net Income (Loss) Attributable to Parent 450M USD -45.9%
Earnings Per Share, Basic 5.41 USD/shares -42.6%
Earnings Per Share, Diluted 5.38 USD/shares -42.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 265M USD -86.3%
Accounts Receivable, after Allowance for Credit Loss, Current 2.09B USD +9.67%
Inventory, Net 442M USD -9.43%
Assets, Current 3.57B USD -30.3%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 2.93B USD +6.17%
Operating Lease, Right-of-Use Asset 737M USD -0.14%
Intangible Assets, Net (Excluding Goodwill) 3.33B USD +5.64%
Goodwill 6.22B USD +0.62%
Other Assets, Noncurrent 639M USD +50%
Assets 16.7B USD -5.68%
Accounts Payable, Current 761M USD +6.66%
Employee-related Liabilities, Current 431M USD -2.97%
Accrued Liabilities, Current 708M USD +7.56%
Liabilities, Current 4.06B USD +86.2%
Operating Lease, Liability, Noncurrent 643M USD +3.06%
Other Liabilities, Noncurrent 484M USD +15.6%
Liabilities 8.69B USD -2.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -192M USD -24.9%
Retained Earnings (Accumulated Deficit) 8.18B USD -7.45%
Stockholders' Equity Attributable to Parent 8.01B USD -22.6%
Liabilities and Equity 16.7B USD -5.68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.8M USD -125%
Net Cash Provided by (Used in) Financing Activities -11.7M USD +80.7%
Net Cash Provided by (Used in) Investing Activities -393M USD -294%
Common Stock, Shares Authorized 265M shares 0%
Common Stock, Shares, Issued 83.9M shares -4.88%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -438M USD -1112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.93B USD +97.3%
Deferred Tax Assets, Valuation Allowance 150M USD -0.73%
Deferred Tax Assets, Gross 795M USD +15.8%
Operating Lease, Liability 815M USD -0.25%
Payments to Acquire Property, Plant, and Equipment 134M USD +71.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 411M USD -56.5%
Lessee, Operating Lease, Liability, to be Paid 962M USD -6.08%
Property, Plant and Equipment, Gross 5.82B USD +8.15%
Operating Lease, Liability, Current 182M USD +17.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 200M USD -6.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +27.8%
Deferred Income Tax Expense (Benefit) -19.5M USD -172%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 148M USD -7.4%
Deferred Tax Assets, Operating Loss Carryforwards 247M USD +2.07%
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 29.9M USD -20.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 237M USD +30.6%
Depreciation, Depletion and Amortization 155M USD +8.73%
Deferred Tax Assets, Net of Valuation Allowance 645M USD +20.5%
Interest Expense 194M USD -1.12%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%